Answers are grounded in this paper and cite their sources.
Introduction Biomaterials are currently used in a wide range of applications in regenerative medicine, and to date, a large number of compounds have been designed as approach to different nervous system diseases. Bioactive materials contain biologically active compounds such as enzymes, ceramics, drugs, antibiotics, vitamins, growth factors or stem cells that when conjugated with nanoparticles can promote an active response in the host tissue. The present article carries out a systematic review and a critical analysis of the challenges that must be solved in the synthesis of biomaterials and in the evaluation of their therapeutic efficiency. Methodology The present systematic review followed the PRISMA guidelines and included studies from PubMed Databases, published between 1997 and 2020. Results The search resulted in a total of 55 articles eligible for critical analysis. The available literature show that bioactive materials should exhibit two key properties: 1. The chemical–physical characteristics that give rise to the binding between the polymer and the active compound (biocompatibility) and 2. The scaffolds with a biologically active component must have the desired effect on the target within the host tissue. Conclusions The use of bioactive scaffolds is an innovative and personalised approach to many nervous system diseases. The use of new Bioengineering strategies had increased the potential use of these tools in order to resolve daily clinical problems. More studies will be required to assess the efficiency of these strategies in clinical trials and to solve the potential challenges between host and bioactive scaffold response.
No takes yet. Share an insight, caveat, or question.
Ramos-Zúñiga et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: